Kindled seizures do not affect adenosinergic inhibition of DA or ACh release in rat accumbens or PFC

Pharmacology, Biochemistry, and Behavior
A H EngelbrechtJ J Taljaard

Abstract

Epileptic seizures are thought to terminate largely as a result of the extracellular accumulation of the purinergic neuromodulator, adenosine, released by discharging neurons. However, the postictal surge in extracellular adenosine and its widespread inhibitory effects are limited in time to only a few minutes and cannot directly account for increased resistance to seizures and the complex behavioural and motivational effects that may persist for hours or days after a seizure. The present study examined whether kindled seizures might alter the sensitivity or efficacy of inhibitory presynaptic adenosine receptors, and thereby induce more enduring changes in downstream transmitter systems. Rats were kindled in the amygdala of the dominant cerebral hemisphere, contralateral to the preferred direction of rotation, and their brains were removed either 2 h or 28 days after completion of kindling. Inhibition of electrically stimulated release of dopamine (DA) and acetylcholine (ACh) by the A1 adenosine-receptor agonist, R-phenylisopropyladenosine (R-PIA) was then measured in the prefrontal cortex (PFC) and nucleus accumbens. R-PIA (1.0 microM) inhibited [1H]DA release from PFC and nucleus accumbens tissue, and [14C]ACh release from nu...Continue Reading

References

Jun 1, 1979·Experimental Neurology·J A MessenheimerO Steward
Aug 25, 1978·Brain Research·R A Wise
Feb 1, 1977·Experimental Neurology·R F Mucha, P J Pinel
Jan 1, 1992·Experimental Brain Research·A Represa, Y Ben-Ari
Dec 1, 1992·Neuroscience·S FerréB B Fredholm
Jan 1, 1991·Progress in Neurobiology·R W Greene, H L Haas
Dec 1, 1991·Brain Research Bulletin·L Kokkinidis, T B Borowski
May 1, 1991·Pharmacology, Biochemistry, and Behavior·S A Josselyn, R J Beninger
Jan 1, 1991·Reproduction, Fertility, and Development·R G KingT J Rook
Jan 1, 1990·Annals of the New York Academy of Sciences·G Burnstock
Aug 1, 1990·Pharmacology, Biochemistry, and Behavior·M Dragunow
Aug 1, 1990·Epilepsy Research·K WhitcombR F Berman
Jul 1, 1990·Journal of Neurochemistry·S J BrownP J Richardson
Jan 1, 1989·Neuroscience and Biobehavioral Reviews·M DragunowK Jansen
Mar 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·U Trendelenburg
Jan 1, 1985·Annual Review of Neuroscience·S H Snyder
Feb 1, 1988·Biological Psychiatry·J G CsernanskyL Lombrozo
Jan 1, 1988·Progress in Neurobiology·M Dragunow
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Apr 1, 1987·Experimental Neurology·M MintzL J Herberg
Jun 1, 1986·Pharmacology, Biochemistry, and Behavior·T E Albertson
Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Apr 1, 1974·Neuropharmacology·T P Jerussi, S D Glick
Sep 3, 1984·European Journal of Pharmacology·R CorradettiG Pepeu
Oct 15, 1981·European Journal of Pharmacology·M P WybengaH A Robertson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.